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ABSTRACT  We have previously shown that the cholecystokinin  (CCK)-binding  proteins in rat 
pancreatic  plasma membranes consist of a major Mr 85,000 and  minor  Mr 55,000 and Mr 
130,000 species as  revealed by  affinity  labeling  with  1251-CCK-33 using the  cross-linker, 
disuccinimidyl  suberate. The  glycoprotein  nature  of  these species was  investigated using 
endoglycosidase F (endo F) and neuraminidase treatment and wheat germ agglutinin-agarose 
chromatography. Treatment of affinity-labeled  membranes with endo F resulted in increased 
electrophoretic  mobilities of all three binding  proteins, indicating removal of N-linked  oligo- 
saccharide side chains. Endo F treatment of each protein in gel slices indicated the following 
cleavage relationships: Mr 85,000 --~ 65,000; Mr 55,000 --~ 45,000; Mr  130,000 --~  110,000. 
Using limiting enzyme conditions  to digest each protein contained  in excised SDS gel slices, 
three and four products, respectively, were identified  for the Mr 85,000 and 55,000 proteins. 
Similar treatment  of the Mr  130,000 protein  revealed only the  Mr  110,000 product.  These 
results indicated  that the Mr 85,000 protein  has at least three, the Mr 55,000 protein  has at 
least four, and the Mr 130,000 protein has at least one, N-linked oligosaccharide side chain(s) 
on  their  polypeptide  backbone.  Neuraminidase  treatment  of  affinity-labeled  membranes 
caused slight increases in the electrophoretic  mobilities  of all three  proteins, indicating the 
presence of sialic acid residues. Solubilization of affinity-labeled  membranes in Nonidet P-40 
followed by affinity chromatography on wheat germ agglutinin-agarose revealed that all three 
CCK-binding  proteins specifically interact with this lectin and can be eluted with N-acetyl-o- 
glucosamine. Analysis of the proteins present in the eluted fractions by silver staining indicated 
a significant enrichment  for  proteins  having molecular weights corresponding  to the major 
CCK-binding  proteins  in comparison  to the  pattern of native membranes. Taken together, 
these studies provide  definitive  evidence that the CCK-binding  proteins in rat pancreas are 
(sialo)glycoproteins. 
Cholecystokinin (CCK)  ~  has many effects on its target tissues, 
including stimulation of secretory protein discharge by pan- 
creatic acinar cells, contraction of gall bladder smooth muscle 
cells,  and  presumably a  change in  the activity of neuronal 
cells  in  brain  (1,  2).  In  the  pancreatic  acinar  cell,  CCK 
increases calcium levels (3), the phosphorylation of ribosomal 
t Abbreviations  used  in  the paper:  CCK, cholecystokinin; PMSF, 
phenylmethanesulfonylfluoride;  STI, soybean  trypsin inhibitor; DTT, 
dithiothreitol; DSS, disuccinimidyl  suberate; HMS, 25 mM HEPES, 
5 mM MgCI2, and  104 mM NaC1; MBS, m-maleimidobenzoyl N- 
hydroxysuccinimide  ester; NP-40, Nonidet P-40; WGA, wheat germ 
agglutinin; GicNAc: N-acetyl-D-glucosamine;  endoglycosidase,  endo- 
~-N-acetylglucosaminidase;  endo F, endoglycosidase  F. 
protein $6 (4), and enzyme secretion (5) after interaction with 
its plasmalemmal  receptor. Specific binding sites  for CCK 
have been demonstrated in  isolated pancreatic acini  (6-8), 
and pancreatic membranes (9,  10), and, using light and elec- 
tron microscopic autoradiography, a distinct polarized distri- 
bution of CCK receptors on the basolateral plasmalemma of 
pancreatic acinar cells has been shown in keeping with CCKs 
presumed site of action in this tissue (11,  12). 
Progress toward characterization of  the structural properties 
of  the CCK receptor in pancreas has recently been made using 
affinity cross-linking techniques (12-14). We previously de- 
scribed the identification of a major CCK-binding protein of 
Mr 85,000 and minor CCK-binding components of  Mr 55,000 
and Mr  130,000  in rat pancreatic plasma membranes using 
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linked  samples in  the  absence of reductant  by SDS PAGE 
revealed all of these proteins plus an additional Mr ~ 140,000 
component. On the basis of these findings, we suggested that 
the  Mr  85,000  protein  was  involved,  to  some  extent,  in 
disulfide-linked complexes in native pancreatic membranes. 
Svoboda et  al.  (15)  described the  specific labeling  of a  Mr 
76,000  CCK-binding protein  in  rat pancreatic  membranes. 
Under nonreducing conditions the Mr 76,000 protein was not 
detectable but a  Mr  126,000  and a Mr 96,000  protein were, 
strongly suggesting that under these conditions the Mr 76,000 
component was disulfide-linked to other membrane proteins. 
They did  not  observe a  Mr  55,000  component.  Similarly, 
Sakamoto et al.  (13)  reported the  specific labeling of a  Mr 
80,000  binding protein in  membranes isolated from disper- 
sions of mouse pancreatic acini. Subsequently, several of these 
authors (14) went on to find that the Mr 80,000 protein was 
involved in a disulfide-linked complex (3//, 120,000)  in native 
membranes. They concluded  that  the  CCK receptor has a 
subunit structure consisting of two proteins: one Mr 76,000 
CCK-binding protein disulfide bonded to a Mr 40,000 protein 
that does not bind CCK. Taken together the results of all the 
aforementioned studies suggest  that the major CCK-binding 
protein in native pancreatic membranes and thus the minimal 
structure of the CCK receptor has an apparent Mr of 76,000- 
85,000 (71,000-81,000 native-corrected for the mass of CCK) 
that exists both free and disulfide bonded to a  Mr 40,000- 
55,000 protein. The relationship of  the additional components 
observed to this complex is unknown. 
We now report that the affinity labeled Mr 85,000, 55,000 
and  130,000  CCK-binding proteins are sialoglycoproteins us- 
ing as criteria alteration  in  apparent molecular weight after 
endoglycosidase F (endo F) treatment (16) or neuraminidase 
treatment,  and  specific  binding  to  wheat  germ  agglutinin 
(WGA).  Digestion  of proteins  contained  in  bands  excised 
from gels was carried out with limiting amounts of endo F to 
provide an approximation of the total number of N-linked 
oligosaccharides each contains.  This work  has appeared in 
abstract form (17). 2 
MATERIALS  AND  METHODS 
Reagents 
Synthetic  CCK-8  was  the  generous  gift of Dr.  Miguel Ondetti  (Squibb 
Institute  for Medical Research, Princeton,  N  J). Natural  Porcine CCK-33 was 
obtained  from Dr. Viktor Mutt (Gastrointestinal  Hormone Research Labora- 
tory, Karolinska  Instituter,  Stockholm, Sweden). Endo H was a gift from Dr. 
Paul Atkinson (Albert Einstein College of Medicine, Bronx, NY). Neuramini- 
dase (EC 3.2. I. 18) Type X, Bacitracin, phenylmethylsulfonyl fluoride (PMSF), 
and proteins  used for molecular  weight standards  were obtained  from Sigma 
Chemical Co. (St. Louis, MO). Soybean trypsin inhibitor  was purchased from 
Worthington  Diagnostics  (Freehold,  N  J).  Monoiodinated  BoRon-Hunter  re- 
agent was purchased  from New England  Nuclear (Boston, MA) (>2,000  Ci/ 
mmol) or ICN Pharmaceuticals (Irvine, CA) (>1,500 Ci/mmol). 
Iodination of CCK-33 
CCK-33 was acylated with ~2~I-labeled Bolton-Hunter  Reagent essentially as 
described  by Sankaran  et al.  (6) and  Rehfeld (19). Derivatized  peptide  was 
separated  from underivatized  peptide  and unreacted,  hydrolyzed reagent  by 
chromatography  on a column (1.6 x  100 cm) of Sepbadex G-50 (superfine), 
equilibrated,  and eluted  with  0.5  M acetic  acid, pH 2.40, containing  0.2% 
gelatin and 50 #M DTT as previously reported (12). 
2 This work  was presented  at  a  satellite  meeting  of the  American 
Pancreatic Association entitled, "Pancreatic Physiology," held in Lake 
of the Ozarks, MO, November l  and 2,  1983. 
Preparation of Pancreatic Plasma Membranes 
Rat pancreatic plasma membranes were prepared from 125-150 g male rats 
(Charles River  Breeding Laboratories,  Charles  River,  MA) as previously re- 
ported (12). Membranes were stored under liquid N2 as 300 #g suspensions (l 
gg/gl) in HMS (25 mM HEPES, 5 mM MgC12, and  104 mM NaCl) oH 7.4, 
containing  0.2% BSA, 0.01% soybean trypsin inhibitor  (STI),  1 mM PMSF, 
and I mM bacitracin. 
Affinity-labeling  Procedure 
Membranes were affinity cross-linked with ~25I-CCK-33 in conjunction  with 
disuccinimidyl substrate (DSS) or m-maleimidobenzoyl N-hydroxysuccinimide 
ester (MBS) essentially as described by Pilch and Czech ( l 8). Membranes were 
thawed  at  room  temperature  and  centrifuged  for 2  min  (12,000 g)  in  a 
Brinkmann M,odd  3200 Microfuge.  Pellets were  resuspended  in 0.2  ml  of 
HMS,  pH  7.4, c~ntaining  0.2% BSA, 0.01% STI,  1 mM  PMSF,  l  mM 
bacitracin,  and  ~25I-CCK-33 (1-2  nM) by gentle agitation.  Incubations  were 
carried out for 15 rain at 23°C at the end of which time the tubes were placed 
on ice and  l  ml of ice-cold HMS, pH 7.4, containing  0.2% BSA and 0.01% 
STI was added  to each tube.  Membranes  were pelleted by centrifugation  at 
12,000 g for 2 rain and placed on ice. Pellets were resuspended in 98 ~l of ice- 
cold HMS,  pH 7.4, and 2 ul of a 2.5  mM solution  of DSS or MBS freshly 
dissolved in dimethylsulfoxide was added yielding a final concentration  of 50 
~,M of each reagent. Cross-linking was allowed to proceed  for 5 min on ice 
followed by quenching with 20 mM Tris, pH 7.4 (supplemented with 50 or 20 
mM  2-mercaptoethanol  for  MBS-containing  tubes),  and  centrifugation  at 
12,000 g for 4 rain to yield a final pellet for analysis by gel electrophoresis or 
endoglycosidase treatment. 
Preparation of Endo F 
Endo F was either  obtained  as a gift from Drs. John Elder and Stephen 
Alexander (Research Institute  of Scripps Clinic) or prepare d from suspension 
cultures of Flavobacterium meningosepticum (American Type Culture Collec- 
tion, Rockville, MD) essentially as described by Elder and Alexander (16). Cells 
were separated from culture medium by centrifugation  at 5,000 g for l0 min 
at  room temperature.  The supernatant was then brought to  80%  saturated 
ammonium sulfate (560 g/l). After mixing for l h at 4°C and centrifugation at 
10,000 g for 20 min, the precipitate that had collected along the walls of the 
centrifuge bottles was recovered by resuspension in 50% ammonium sulfate in 
5 mM EDTA (100 ml). This was then centrifuged at 20,000 g for 15 min and 
the dark green precipitate obtained was "extracted" by resuspension in 0.01 M 
Na phosphate, pH 7.2, 150 mM NaCI, and 50 mM EDTA and vortexing. This 
suspension was centrifuged at  10,000 g for 2 min and the final supernatant 
applied to a column (1.5 x 55 cm) of  Ultrogel AcA 54 (LKB, Bromma, Sweden) 
in 0.01 M Na phosphate,  pH 7.2, 150 mM NaCl, 5 mM EDTA, and 0.05% 
NAN3. Aliquots (5 #l) of each column fraction were tested for endo F activity 
by assaying their ability to cleave oligosaccbarides from ovalbumin or RNase 
B.  The peak  fractions  were pooled,  dialyzed  against  column buffer  lacking 
NAN3, concentrated  against  Aquacide  II-A (Calbiochem-Behring  Corp.,  La 
Jolla, CA) and diluted  1: l with glycerol. The enzyme was stored in 0. I M Na 
phosphate pH 6. l, 50 mM EDTA and 50% glycerol at -20°C at a concentration 
of  l  U/~l.  l  U  of activity  is defined  as that amount of enzyme  that will 
deglycosylate l nmol of RNase B in l h at 37°C (as per New England Nuclear). 
Endo F Treatment of Affinity-labeled Samples 
MEMBRANES:  In preparation  for digestion with endo F, affinity-labeled 
membrane pellets (300 ~g) were resuspended in 0.2 ml of digestion buffer: 0.1 
M Na phosphate, pH 6.1, containing  50 mM EDTA,  1% Nonidet  P-40, 0.1% 
SDS, and 1% 2-mercaptoethanol.  Samples were then heated at 100°C for 3 rain 
and allowed to cool to room temperature.  Endo  F and/or buffer  was then 
added to each membrane aliquot (50 ~,1) and digestion was allowed to proceed 
for 2 h at 37°C. An equal volume of SDS sample buffer was then added to each 
sample followed by heating at 100°C for 3 min and analysis by SDS PAGE. 
G E L  S L I C E S :  For treatment of  individual binding proteins, affinity-labeled 
membranes were resolved on 9% acrylamide gels under reducing conditions. 
The affinity-labeled binding proteins (Mr 130,000, Mr 85,000, and Mr 55,000) 
were located  by  autoradiography  of the dried,  unfixed,  unstained  gels, and 
excised. Each gel slice was placed in a separate tube and rehydrated in 0.18 ml 
of endo F digestion buffer. The accessibility of enzyme to substrate was then 
increased  by  sequentially  freeze-thawing the  tubes through three  cycles of 
alternate  incubation  in a dry ice-methanol  bath/37°C  water bath for l0 min 
each. Endo F and/or buffer was then added to each tube and the incubation 
allowed to proceed for 24 h at 37°C with gentle shaking. The incubation  was 
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100*C for 3 min. The samples (gel pieces and incubation buffer) were resolved 
on a second 9% acrylamide gel having a 4-cm stacking gel. 
Neuraminidase Treatment of Affinity- 
labeled Membranes 
For neuraminidase treatment, affinity-labeled  membrane pellets were resus- 
pended in a final 0.2 ml volume of 50 mM HEPES, pH 5.0, containing 5 mM 
MgCI2, and 0.15 M NaCI with or without 1 U of neuraminidase (Sigma Type 
X,  from Clostridium  perfringens).  After a  30-min incubation at  37"C, the 
membranes were pelleted and solubilized  in preparation for electrophoresis. 
WGA-Agarose Chromatography 
WGA was immobilized on agarose by reacting 10 mg WGA (Pharmacia 
Fine Chemicals, Uppsala, Sweden) with 5 ml of Reacti-gel  (6x) (Pierce Chem- 
ical Co., Rockford, IL) in 0.1  M Na borate, pH 8.5 (5 ml), at 4"C for 48 h. 
After quenching with 0.1  M glycine in 0.1  M Na borate, pH 8.5, for 3 h at 
23"C, the derivatized agarose was sequentially washed with 0.1  M NaHCO3, 
0.5 M NaCI, 50 mM HEPES, pH 7.5, 0.5 M NaCI, 50 mM HEPES, pH 7.5, 
0.1 M NaCI, and stored at 4"C in the latter buffer containing 0.05% Na azide. 
For affinity chromatography, 0.4 ml of WGA-agarose was equilibrated in 50 
mM HEPES, pH 7.5, containing 0.1 M NaCI and 0.1% NP-40. After affinity 
labeling, membranes (300 pg) were solubilized in HMS containing 0.2% BSA, 
0.01% STI, 1 mM PMSF, 1 mM bacitracin, and 2% NP-40 by gentle agitation 
and incubation on ice for 15 min. Insoluble material was removed by centrif- 
ugation at  100,000 g.v for 60 min. The soluble fraction was diluted to 0.2% 
NP-40 by addition of 50 mM HEPES, pH 7.5, containing 0.1  M NaCI and 
added to the WGA-agarose beads. After incubation for 15 min at 23"C, the 
suspension was packed into a column (0.8 x  4 cm). The flow-through was 
recycled  three times and the gel was sequentially washed with 2 ml each of 0.1 
M NaC1, 0.5 M NaCI, and finally 0.3 M GlcNAc in 0.5 M NaC1 all in 50 mM 
HEPES, pH 7.5, containing 0.1% NP-40. SDS sample buffer (0.1 ml) was 
added to each column fraction (0.2 ml) and the samples analyzed on SDS gels 
as described below. 
Gel Electrophoresis and Autoradiography 
Cross-linked membrane pellets or gel slice  digests  were solubilized  in sample 
buffer consisting of 0.125 M Tris, pH 6.8, containing 4% SDS, 10 mM EDTA, 
15 % sucrose, 0.1 M DTT, and 0.01% bromophenol blue, heated at 100*C for 
3 min and run on 9% acrylamide slab gels  (11 cm x 0.75 or 1.5 mm) containing 
2 mM  EDTA according to  the  method described by Laemmli (20). After 
electrophoresis, the gels were fixed and stained with Coomassie Brilliant Blue 
(21 ) or with the silver stain (22). The dried gels were exposed to Kodak XAR- 
5 x-ray film for 2-21 d using a Dupont Cronex light intensifying  screen. 
RESULTS 
To  determine  whether  the  CCK-binding  proteins  identified 
in  rat  pancreatic  plasma  membranes  are  glycoproteins,  we 
initially chose to test their sensitivities to treatment with endo 
F. This enzyme has been shown to cleave both mannose-rich 
and  complex  N-linked  oligosaccharide  side  chains  en  bloc 
from glycoproteins (16).  As shown  in  Fig.  1,  when  affinity- 
labeled  membranes  were  treated  with  endo  F,  a  consistent 
decrease  in  the  apparent  molecular  weights  of  the  CCK- 
binding  proteins  was  observed.  These  results  suggested  the 
following  cleavage  pattern:  Mr  130,000  to  >110,000;  Mr 
85,000 tO >65,000; Mr 55,000 tO >45,000.  These assignments 
were confirmed by treating each  individual binding protein, 
obtained  by excision  from  an  unfixed gel, with  endo  F  and 
analyzing the cleavage products (Fig. 2). 
Assuming that the cleavage products shown in Figs.  1 and 
2 represent the affinity-labeled binding proteins, devoid of N- 
linked  oligosaccharide  chains,  it  was  next  of interest  to  at- 
tempt to "capture" intermediate cleavage forms of each pro- 
tein in order to estimate the total number of N-linked oligo- 
saccharide  side chains  present  in  each  of these proteins.  To 
this end, affinity-labeled membrane proteins were resolved by 
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FIGURE  1  Endo F treatment of affinity cross-linked  plasma mem- 
branes.  Rat pancreatic  plasma membranes  (300 pg) were affinity 
cross-linked with ~251-CCK-33 using DSS as described.  Cross-linked 
membranes were resuspended  in 200 ~1 of endo F sample buffer 
and boiled for 3 min. After cooling, endo F  and/or buffer was added 
to each 50-#1 aliquot and the samples incubated at 37°C for 2 h. 
Incubations were terminated by  the addition of electrophoresis 
sample buffer.  The samples were resolved on a 9% SDS gel and 
the dried gel was subjected  to autoradiography. Arrows  indicate 
the migration positions of untreated binding proteins. Arrowheads 
indicate final endo F cleavage products.  In this experiment, 1 pl of 
enzyme is equal to 5 U of activity. 
SDS  PAGE and  the CCK-binding proteins  localized by au- 
toradiography  of the  dried,  unfixed,  unstained  gel,  excised, 
and  subjected  to  limited  endo  F  digestion  as  described  in 
Materials and Methods. The results obtained (Fig. 3) indicated 
that the Mr 55,000  component contains at least four, the Mr 
85,000 component contains at least three, and the Mr 130,000 
component  contains  at  least  one  N-linked  oligosaccharide 
side chain(s) within their structures. 
We have previously reported  the  specific affinity labeling 
of a  Mr 85,000  protein  in rat pancreatic plasma  membranes 
using the heterobifunctional  SH, NH2 reactive reagent MBS 
(23;  L.  D.  Madison,  S.  A.  Rosenzweig, and  J.  D. Jamieson, 
manuscript  submitted  for publication).  As shown  in  Fig.  4, 
the Mr 85,000 CCK-binding protein identified by MBS cross- 
linking  contains  three  N-linked  oligosaccharide  side  chains 
with  a  major  digestion  product  of Mr  65,000.  This  lends 
evidence in support  of this protein being identical to the Mr 
85,000  protein labeled using DSS. It should be noted that in 
the case of the Mr 85,000  protein, even at the highest dose of 
endo F  used (Fig.  3),  complete cleavage was not obtained  as 
minor labeled bands were detected above and below the major 
Mr 65,000  cleavage product (see also Figs.  1 and 4). This was 
consistently observed for the 3,/, 85,000  protein labeled with 
either  DSS  or  MBS.  It  is  not  known  whether  this  lack  of 
complete cleavage was due  to  inaccessibility of the cleavage 
site(s), because the cross-linking made these sites inaccessible, 
or was due to lack of sufficient endo F for complete digestion. 
When  endo  H  (which  cleaves mannose-rich  N-linked  oli- gosaccharides exclusively [24]), was used in similarly designed 
experiments, no change in the electrophoretic mobilities of 
any of these proteins was detected (data not shown). These 
results  suggested  but  do  not  prove  that  all  the  N-linked 
oligosaccharides identified by endo  F  treatment  might  be 
FIGURE 2  Endo  F  treatment  of  individual affinity-labeled CCK 
binding  proteins.  Affinity  cross-linked  plasma  membranes  were 
divided into several equal parts (50 #g of membrane protein) and 
electrophoresed on a 9% gel. The unfixed, dried gel was autoradi- 
ographed and the radioactive bands were located. Gel bands were 
excised,  rehydrated in sample  buffer and their porosity increased 
by sequential freeze-thrawing as described.  Enzyme and/or buffer 
was then  added and  the  samples  incubated for  24  h  at  37°C. 
Incubation was terminated by  addition of 50 ul  of SDS  sample 
buffer and the gel slices and  buffer loaded onto a 9% gel. After 
electrophoresis,  the  gels  were  fixed,  stained,  and  subjected  to 
autoradiography.  Plus signs indicate those samples that were treated 
with  20  U  of endo  F.  Arrows  on  left  indicate the  positions  of 
untreated binding proteins.  Arrows on right indicate positions  of 
the major endo E cleavage products. 
complex.  Because  most  complex  oligosaccharides  contain 
terminal  sialic  acid  residues,  we  tested  the  attinity-labeled 
binding proteins for sensitivity to neuraminidase. Fig. 5 shows 
that the electrophoretic mobilities of  all three binding proteins 
were increased by neuraminidase treatment, supporting the 
classification of these proteins as sialoglycoproteins. Whether 
all of the N-linked oligosaccharide side chains identified con- 
tain  sialic  acid  (and  are  thus  complex) is  currently under 
investigation. 
Additional support for the sialoglycoprotein nature of the 
affinity-labeled CCK-binding proteins was obtained by chro- 
matography  on  WGA-agarose  (WGA  specifically binds  to 
sialic acid- and GlcNAc-containing glycoproteins [25,  26]). 
As shown in Fig. 6A, all three CCK-binding proteins bound 
to the lectin and could be specifically  eluted with GlcNAc. 
However, it is not known whether each protein directly inter- 
acted with the lectin or indirectly by association with other 
membrane glycoproteins in  mixed  micelles.  Based  on  the 
pattern of silver stained proteins shown in Fig. 6 B, it can be 
seen that the GlcNAc-eluted fractions were enriched in pro- 
teins having Mrs corresponding to those of the major CCK- 
binding proteins.  However, it is  not  known whether these 
silver-stained proteins represent the  CCK-binding  proteins 
exclusively  or these proteins plus additional pancreatic plasma 
membrane glycoproteins having similar molecular weights. 
Nonetheless, it is clear that WGA-agarose affinity chromatog- 
raphy of pancreatic membranes yields a several-fold enrich- 
ment in these glycoproteins thus providing both an effective 
method  for the  partial  purification  of CCK  receptors and 
additional evidence of their glycoprotein nature. 
DISCUSSION 
Many polypeptide hormone receptors have been considered 
to be glycoproteins on  the  basis  of their interactions with 
various lectins (27-30). In the present study, we used sensitiv- 
ity to cleavage by endo F to initially determine whether the 
CCK-binding proteins in pancreatic membranes were glyco- 
FIGURE 3  Dose-dependent endo F treatment of individual CCK-binding proteins.  Individual affinity-labeled binding proteins 
were obtained and treated with various  doses of endo F as described in the legend  to Fig. 2. Arrows indicate the migration 
positions of untreated binding proteins. Arrowheads indicate the different species generated and thus indicate an approximation 
of the total number of N-linked oligosaccharide  side chains present in each binding protein. Mr, X 10  -3. 
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linked with MBS. Plasma membranes cross-linked to ~2sl-CCK-33 
with MBS were resuspended in endo F buffer, boiled for 3 min and 
processed  for endo F treatment as described in the legend to Fig. 
1. For the purpose of clarity, only the Mr 50,000-100,000 region of 
the gel is shown. 
proteins. An added benefit to this approach was that it also 
enabled us to  determine the  minimal number of N-linked 
oligosaccharide side chains present on these proteins. Given 
that endo H treatment was without effect but that neuramin- 
idase  digestion  affected  all  three  components and  that  all 
could specifically bind to WGA, we suggest that some if not 
all  of the  endo  F-sensitive  N-linked  oligosaccharide  side 
chains are of the complex variety (31).  Whether any of these 
proteins contain O-linked oligosaccharide side chains is cur- 
rently under investigation. 
We have previously shown (12) that the Mr 85,000  com- 
ponent is the  major CCK-binding protein  in  pancreas and 
that it exists both free and in disulfide linkage with another 
membrane protein to yield a Mr ~ 140,000  protein complex. 
This complex is only detectable in gels run in the absence of 
reductant. Sakamoto et al. (14) and Svoboda et al. (15) have 
made similar observations. Because the conditions we used 
for optimal endo F cleavage required the use of 1% 2-mercap- 
toethanol (16), it was not possible to study the disulfide-linked 
form  of the  CCK  receptor.  We  are  currently  testing  the 
efficiency of endo F cleavage of the CCK-binding proteins in 
the absence of reductant in order to analyze this complex. It 
should  contain  at  least three  N-linked  oligosaccharide side 
chains contributed by the Mr 85,000 protein. If the disulfide- 
linked subunit of this protein is also a glycoprotein, we should 
detect additional N-linked oligosaccharides by endo F cleav- 
age. 
The use ofendo F to probe CCK receptor structure has lent 
further insight into the lack of relation between the different 
CCK-binding proteins. Specifically, it was found that the Mr 
85,000  protein had three (-20,000  shift in Mr)  and the Mr 
55,000 protein had four (~10,000 shift in Mr) N-linked oli- 
gosaccharide side chains. Assuming that under the conditions 
used we detected  all the  endo  F  products  of each  binding 
protein,  then  it  is  unlikely  that  the  MT  55,000  protein  is 
generated from the Mr 85,000 protein by proteolysis as pre- 
viously suggested (12-14), since it contains one more carbo- 
hydrate side chain than its putative precursor. Limited peptide 
mapping  analysis  of these  proteins  is  consistent  with  this 
notion (17). In addition, the Mr 130,000 component (~20,000 
shift in Mr) was found to possess only one N-linked oligosac- 
charide side chain suggesting that it is a distinct polypeptide 
and  thus  structurally  unrelated  to  the  Mr  85,000  and  Mr 
55,000 components. However, this must be interpreted with 
caution since it is possible that the Mr  130,000  component 
contains more than one N-linked oligosaccharide and we are 
not resolving its endo  F  digestion intermediates on the  9% 
gels used in this study. Whether the Mr 55,000 and Mr 130,000 
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proteins are nearest neighbors to the Mr 85,000 protein and 
as such become specifically labeled during cross-linking or are 
noncovalently associated subunits of a  multicomponent re- 
ceptor is not clarified by the present study. 
The use of endo F to compare the polypeptide backbones 
of the Mr 85,000  binding protein obtained by DSS or MBS 
cross-linking lends  additional  support to  the  relatedness of 
these two proteins and therefore to the hypothesis that the Mr 
85,000 protein is the major (CCK) recognition subunit of the 
CCK receptor. Furthermore, this kind of observation exem- 
plifies the  utility of endo  F  as a  general  probe of the  core 
protein structure of glycoproteins. In combination with endo 
H  cleavage data, endo F  digestion can provide information 
on the number of N-linked oligosaccharide side chains present 
on a given glycoprotein as well as whether they are simple or 
complex. Additionally,  removal of all  N-linked glycans by 
endo F before peptide mapping studies should allow complete 
proteolysis to take place (32). 
In summary, we used sensitivity to endo F digestion as an 
indication  of the  presence of N-linked oligosaccharide side 
chains on the CCK-binding proteins on rat pancreatic mem- 
FIGURE  5  Neuraminidase treatment of affinity cross-linked plasma 
membranes. Plasma membranes were affinity cross-linked to 1251- 
CCK-33  with DSS as described and resuspended in a final 0.2  ml 
volume of 50 mM HEPES, pH 5.0 containing 5 mM MgCIz and 0.15 
M  NaCI  with or without  1  U  of  neuraminidase. After a  30-min 
incubation at 37°C, the membranes were pelleted and solubilized 
in preparation for electrophoresis. Samples were resolved on a 9% 
gel and following fixing and staining the gel was autoradiographed. 
Arrows indicate the migration positions of untreated binding pro- 
teins.  Arrowheads indicate the  migration positions of neuramini- 
dase-treated binding proteins. FIGURE 6  Chromatography of affinity-labeled CCK-binding proteins on WGA-agarose.  Rat pancreatic  plasma membranes (300 
/zg) were affinity cross-linked  to 1251-CCK-33  with DSS, solubilized with NP-40 and incubated with WGA-agarose as described. 
(A) Autoradiographic pattern of fractions  1-9 of the final flow-through and of the first  nine fractions  of the GIcNAc eluate. (B) 
Protein pattern of the corresponding gels in A stained with the silver stain. 
branes.  The advantage of this approach was demonstrated by 
the ability to additionally determine the minimal number of 
oligosaccharide side chains on the major Mr 85,000 binding 
protein and therefore the Mr of its N-linked carbohydrate-free 
polypeptide  core.  This  approach  was  also  instrumental  in 
allowing structural comparisons to be made between binding 
proteins labeled  by different cross-linking reagents  and thus 
provided convincing evidence of their structural relatedness. 
Further studies are required for a more detailed  analysis of 
the  structure of the CCK receptor,  including generation of 
specific immunologic probes. In this regard, it should be noted 
that  in generating monoclonal antibodies to the  epidermal 
growth  factor  receptor  of A-431  cells, Richert  et  al.  (33) 
obtained an antibody specific for human blood group H type 
I oligosaccharides.  Although these antigenic determinants are 
present  in  O-linkage  to  serine  or  threonine  residues  (34), 
removal of N-linked oligosaccharide side chains using endo F 
may be  a  useful  step  in  the  preparation  of antigens.  The 
polypeptide backbones so obtained can then be used as im- 
munogen in generating polyclonal and monoclonal antibod- 
ies, thus reducing the chance of obtaining carbohydrate di- 
rected antibodies, particularly in proteins having little  or no 
O-linked oligosaccharides. 
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